Partnership Approach

Together with our strategic partners in China, Biosilu Healthcare generates a tailored solution to accelerate the development of innovative speciality biopharmaceuticals for the Chinese / Asian markets.

Our preferred approach is the generation of dedicated legal entities (joint ventures) built around a specific asset or class of assets. This newly formed legal entity will hold all the rights on this(these) asset(s) for the respective territory. The exact jurisdiction, set-up details etc. can be adjusted to the (specific) needs of our partners and co-investors. This approach allows for a strong alignment interest of all shareholders and transparent and clear governance principles.

 

 

合作方式

在我们顶级的中国战略伙伴辅佐下,柏丝路医疗为各创新专研药成功进入中国/亚洲市场定制解决方案

我们首选的合作方式是为每种(类)药品资产创建相应的法人实体(合资企业)。新建的公司将持有此产品在中国地域的所有权益。具体管辖权、创建细节等将会因我们的合作伙伴和共同投资者的个别需求而作调整。此合作方式有效确保各股东间的利益高度一致以及清晰明确、具透明度的治理原则。